Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hope S Rugo

Showing results (1-10 of 540) with videos related to

Pageof 54
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Management of toxicities from antibody-drug conjugatesHope S Rugo
The New England Journal of Medicine|July 25, 2019
Achieving Improved Survival Outcomes in Advanced Breast CancerHope S Rugo
Hematology/Oncology Clinics of North America|May 22, 2007
Hormonal therapy for advanced breast cancerHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
Highlights in breast cancer from the 2018 American Society of Clinical Oncology annual meetingHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|July 2, 2020
Highlights from the 2019 San Antonio Breast Cancer SymposiumHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|December 1, 2023
Addressing unmet need in the management of patients with ER+/HER2-, ESR1-mutated metastatic breast cancer: clinician's perspectiveHope S Rugo
Current Treatment Options in Oncology|February 22, 2003
Management of breast cancer diagnosed during pregnancyHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancerHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in metastatic breast cancer from the 2020 San Antonio Breast Cancer Symposium: commentaryHope S Rugo
Clinical Breast Cancer|October 29, 2015
Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast CancerHope S Rugo
Pageof 54

Showing results (1-10 of 540) with videos related to

Sort By:
Pageof 54
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Management of toxicities from antibody-drug conjugatesHope S Rugo
The New England Journal of Medicine|July 25, 2019
Achieving Improved Survival Outcomes in Advanced Breast CancerHope S Rugo
Hematology/Oncology Clinics of North America|May 22, 2007
Hormonal therapy for advanced breast cancerHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
Highlights in breast cancer from the 2018 American Society of Clinical Oncology annual meetingHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|July 2, 2020
Highlights from the 2019 San Antonio Breast Cancer SymposiumHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|December 1, 2023
Addressing unmet need in the management of patients with ER+/HER2-, ESR1-mutated metastatic breast cancer: clinician's perspectiveHope S Rugo
Current Treatment Options in Oncology|February 22, 2003
Management of breast cancer diagnosed during pregnancyHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancerHope S Rugo
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in metastatic breast cancer from the 2020 San Antonio Breast Cancer Symposium: commentaryHope S Rugo
Clinical Breast Cancer|October 29, 2015
Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast CancerHope S Rugo
Pageof 54